Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
The ecteinascidin family comprises a number of biologically active compounds, containing two to three tetrahydroisoquinoline subunits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds
Miyaura, N., & Suzuki, A. (1995) · Chemical Reviews · doi:10.1021/cr00039a007 · Cited by 12,817
Metal‐Catalyzed Cross‐Coupling Reactions
(2004) · Wiley eBooks · doi:10.1002/9783527619535 · Cited by 4,267
Metal‐Catalyzed Cross‐Coupling Reactions
(1998) · Wiley eBooks · doi:10.1002/9783527612222 · Cited by 2,529
Fischbach, M. A., & Walsh, C. T. (2006) · Chemical Reviews · doi:10.1021/cr0503097 · Cited by 1,464
Biosynthesis of Nonribosomal Peptides
Finking, R., & Marahiel, M. A. (2004) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123615 · Cited by 888
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Germano, G., Frapolli, R., Belgiovine, C., Anselmo, A., Pesce, S., Liguori, M., Erba, E., Uboldi, S., Zucchetti, M., Pasqualini, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.008 · Cited by 864
The ATM-mediated DNA-damage response: taking shape
Shiloh, Y. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.05.004 · Cited by 541
Demetri, G. D., Chawla, S. P., von Mehren, M., Ritch, P., Baker, L. H., Blay, J. Y., Hande, K. R., Keohan, M. L., Samuels, B. L., Schuetze, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0088 · Cited by 538
Rinehart, K. L., Holt, T. G., Fregeau, N. L., Stroh, J. G., Keifer, P. A., Sun, F., Li, L. H., & Martin, D. G. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00302a007 · Cited by 492
Trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian cancer
Monk, B. J., Herzog, T. J., Kaye, S. B., Krasner, C. N., Vermorken, J. B., Muggia, F. M., Pujade-Lauraine, E., Lisyanskaya, A. S., Makhson, A. N., Rolski, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4037 · Cited by 395
Enantioselective Total Synthesis of Ecteinascidin 743
Corey, E. J., Gin, D. Y., & Kania, R. S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja962480t · Cited by 352
Takebayashi, Y., Pourquier, P., Zimonjic, D. B., Nakayama, K., Emmert, S., Ueda, T., Urasaki, Y., Kanzaki, A., Akiyama, S.-I., Popescu, N., et al. (2001) · Nature Medicine · doi:10.1038/91008 · Cited by 348
Pommier, Y., Kohlhagen, G., Bailly, C., Waring, M., Mazumder, A., & Kohn, K. W. (1996) · Biochemistry · doi:10.1021/bi960306b · Cited by 303
Synthesis of Ecteinascidin ET-743 and Phthalascidin Pt-650 from Cyanosafracin B
Cuevas, C., Pérez, M., Martín, M. J., Chicharro, J. L., Fernández-Rivas, C., Flores, M., Francesch, A., Gallego, P., Zarzuelo, M., de la Calle, F., et al. (2000) · Organic Letters · doi:10.1021/ol0062502 · Cited by 282
Sakaitani, M., & Ohfune, Y. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00290a015 · Cited by 274
Shibasaki, M., Boden, C. D. J., & Kojima, A. (1997) · Tetrahedron · doi:10.1016/s0040-4020(97)00437-7 · Cited by 264
Ecteinascidin 743: A Minor Groove Alkylator That Bends DNA toward the Major Groove
Zewail-Foote, M., & Hurley, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990241l · Cited by 214
Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation
Jin, S., Gorfajn, B., Faircloth, G., & Scotto, K. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6775 · Cited by 206
Rath, C. M., Janto, B., Earl, J., Ahmed, A., Hu, F. Z., Hiller, L., Dahlgren, M., Kreft, R., Yu, F., Wolff, J. J., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb200244t · Cited by 206
Self-citationBiotechnological applications of penicillin acylases: state-of-the-art
Arroyo, M., de la Mata, I., Acebal, C., & Pilar Castillón, M. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-002-1113-6 · Cited by 190
Development of Novel Antioxidants: Design, Synthesis, and Reactivity
Hussain, H. H., Babic, G., Durst, T., Wright, J. S., Flueraru, M., Chichirau, A., & Chepelev, L. L. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo0301090 · Cited by 180
Herrero, A. B., Martín-Castellanos, C., Marco, E., Gago, F., & Moreno, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0179 · Cited by 170
Martinez, E. J., Owa, T., Schreiber, S. L., & Corey, E. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3496 · Cited by 170
Sakai, R., Rinehart, K. L., Guan, Y., & Wang, A. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11456 · Cited by 167
Taamma, A., Misset, J. L., Riofrio, M., Guzmán, C., Brain, E. G. C., Lázaro, L. L., Rosing, H., Jimeno, J. M., & Cvitkovic, E. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1256 · Cited by 161
Damia, G., Silvestri, S., Carrassa, L., Filiberti, L., Faircloth, G. T., Liberi, G., Foiani, M., & D'Incalci, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1221 · Cited by 159
Soares, D. G., Escargueil, A. E., Poindessous, V., Sarasin, A. R., de Gramont, A., Bonatto, D., Henriques, J. A. P., & Larsen, A. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609877104 · Cited by 156
Owen, L. A., Kowalewski, A. A., & Lessnick, S. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001965 · Cited by 155
The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice
Pérez‐Losada, J., Pintado, B., Gutiérrez‐Adán, A., Flores, T., Bañares-González, B., del Campo, J. C., Martín-Martín, J. F., Battaner, E., & Sánchez-García, I. (2000) · Oncogene · doi:10.1038/sj.onc.1203572 · Cited by 149
Izbicka, E., Lawrence, R., Raymond, É., Eckhardt, G., Faircloth, G. T., Jimeno, J. M., Clark, G. M., & VonHoff, D. D. (1998) · Annals of Oncology · doi:10.1023/a:1008224322396 · Cited by 147
Mode of action of trabectedin in myxoid liposarcomas
Giandomenico, S. D., Frapolli, R., Bello, E., Uboldi, S., Licandro, S. A., Marchini, S., Beltrame, L., Brich, S., Mauro, V., Tamborini, E., et al. (2013) · Oncogene · doi:10.1038/onc.2013.462 · Cited by 137
Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells
Grohar, P. J., Griffin, L. B., Yeung, C. L., Chen, Q.-R., Pommier, Y. G., Khanna, C., Khan, J. I., & Helman, L. J. (2011) · Neoplasia · doi:10.1593/neo.101202 · Cited by 130
Ryan, D. P., Supko, J. G., Eder, J. P., Seiden, M. V., Demetri, G. D., Lynch, T. J., Fischman, A. J., Davis, J., Jimeno, J. A., & Clark, J. W. (2001) · PubMed · Cited by 115
Li, L., Deng, W., Song, J., Ding, W., Zhao, Q., Peng, C., Song, W.-W., Tang, G., & Liu, W. (2007) · Journal of Bacteriology · doi:10.1128/jb.00826-07 · Cited by 114
Hendriks, H. R., Fiebig, H., Giavazzi, R., Langdon, S. P., Jimeno, J. M., & Faircloth, G. T. (1999) · Annals of Oncology · doi:10.1023/a:1008364727071 · Cited by 107
Cell-cycle regulation of gene expression by transcriptional repression
Zwicker, J., & Müller, R. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(96)30112-1 · Cited by 102
Role of homologous recombination in trabectedin-induced DNA damage
Tavecchio, M., Simone, M., Erba, E., Chiolo, I., Liberi, G., Foiani, M., D’Incalci, M., & Damia, G. L. M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.01.003 · Cited by 98
Takahashi, N., Li, W. W., Banerjee, D., Scotto, K. W., & Bertino, J. R. (2001) · PubMed · Cited by 96
Sánchez-García, I., & Rabbitts, T. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.7869 · Cited by 92
The combination of yondelis and cisplatin is synergistic against human tumor xenografts
D’Incalci, M., Colombo, T., Ubezio, P., Nicoletti, I., Giavazzi, R., Erba, E., Ferrarese, L., Meco, D., Riccardi, R., Sessa, C., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00490-8 · Cited by 90
Takebayashi, Y., Pourquier, P., Yoshida, A., Kohlhagen, G., & Pommier, Y. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7196 · Cited by 86
DC-52, a novel antitumor antibiotic. 1. Taxonomy, fermentation and biological activity.
Tomita, F., Takahashi, K., & Shimizu, K. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.463 · Cited by 85
Twelves, C. J., Hoekman, K., Bowman, A., Vermorken, J. B., Anthoney, A., Smyth, J., van Kesteren, C., Beijnen, J. H., Uiters, J., Wanders, J., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00458-1 · Cited by 84
NMR-Based Model of an Ecteinascidin 743−DNA Adduct
Moore, B. M., II, Seaman, F. C., & Hurley, L. H. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9704500 · Cited by 81
Guirouilh‐Barbat, J., Redon, C. E., & Pommier, Y. G. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0215 · Cited by 81
DNA and Non-DNA Targets in the Mechanism of Action of the Antitumor Drug Trabectedin
David‐Cordonnier, M., Gajate, C., Olmea, O., Laine, W., de la Iglesia-Vicente, J., Perez, C., Cuevas, C., Otero, G., Manzanares, I., Bailly, C., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.08.009 · Cited by 80
Zewail‐Foote, M., LI, V. ‐., Kohn, H., Bearss, D. J., Guzman, M., & Hurley, L. H. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00071-0 · Cited by 79
Zewail‐Foote, M., & Hurley, L. H. (2001) · Journal of the American Chemical Society · doi:10.1021/ja004023p · Cited by 78
Cesne, A. L., Yovine, A. J., Blay, J., Delaloge, S., Maki, R. G., Misset, J. L., Frontelo, P., Nieto, A., Jiao, J. J., & Demetri, G. D. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9662-0 · Cited by 78
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies
Riccardi, R., Meco, D., Colombo, T., Ubezio, P., Zucchetti, M., Zaffaroni, M., Riccardi, A., Faircloth, G. T., Jose, J., & D’Incalci, M. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0636-6 · Cited by 77
Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA.
Bonfanti, M., Valle, E. L., Faro, J. M. F. S., Faircloth, G. T., Caretti, G., Mantovani, R., & D’Incalci, M. (1999) · PubMed · Cited by 76
Moss, C., Green, D. H., P�rez, B., Velasco, A. L., Henr�quez, R., & McKenzie, J. D. (2003) · Marine Biology · doi:10.1007/s00227-003-1060-5 · Cited by 75
The structure of a novel antitumor antibiotic, saframycin A
Arai, T., Takahashi, K., Nakahara, S., & Kubo, A. (1980) · Cellular and Molecular Life Sciences · doi:10.1007/bf01965946 · Cited by 70
Kanzaki, A., Takebayashi, Y., Ren, X. Q., Miyashita, H., Mori, S., Akiyama, S. I., & Pommier, Y. G. (2002) · PubMed · Cited by 69
Lau, L. M. S., Supko, J., Blaney, S. M., Hershon, L., Seibel, N. L., Krailo, M., Qu, W., Malkin, D. M., Jimeno, J. M., Bernstein, M. L., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.672.11.2 · Cited by 66
Takebayashi, Y., Goldwasser, F., Urasaki, Y., Kohlhagen, G., & Pommier, Y. (2001) · PubMed · Cited by 63
Bacterial diversity associated with the Caribbean tunicate Ecteinascidia turbinata
Perez-Matos, A. E., Rosado, W., & Govind, N. S. (2007) · Antonie van Leeuwenhoek · doi:10.1007/s10482-007-9143-9 · Cited by 61
Takahashi, N., Li, W., Banerjee, D., Guan, Y., Wada-Takahashi, Y., Brennan, M. F., Chou, T., Scotto, K. W., & Bertino, J. R. (2002) · PubMed · Cited by 59
Krasner, C. N., Poveda, A. M., Herzog, T. J., Vermorken, J. B., Kaye, S. B., Nieto, A., Claret, P. L., Park, Y. C., Parekh, T. V., & Monk, B. J. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.06.034 · Cited by 53
Garcı́a-Rocha, M., García-Gravalos, M., & Ávila, J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.176 · Cited by 52
Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells.
Scotlandi, K., Perdichizzi, S., Manara, M. C., Serra, M., Benini, S., Cerisano, V., Strammiello, R., Mercuri, M., Reverter‐Branchat, G., Faircloth, G. T., et al. (2002) · PubMed · Cited by 49
Feuerhahn, S., Giraudon, C., Martínez, M., Bueren‐Calabuig, J. A., Galmarini, C. M., Gago, F., & Egly, J. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.06.007 · Cited by 49
Biosynthesis of 3-Hydroxy-5-Methyl-O-Methyltyrosine in the Saframycin/Safracin Biosynthetic Pathway
Fu, C.-Y., Tang, M.-C., Peng, C., Li, L., He, Y.-L., Liu, W., & Tang, G.-L. (2008) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.0808.484 · Cited by 47
Simoens, C., Korst, A. E. C., Pooter, C. M. J. D., Lambrechts, H. A. J., Pattyn, G. G. O., Faircloth, G. T., Lardon, F., & Vermorken, J. B. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601431 · Cited by 41
Peng, C., Pu, J., Song, L.-Q., Jian, X., Tang, M.-C., & Tang, G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204232109 · Cited by 36
Increased DNA Binding Specificity for Antitumor Ecteinascidin 743 through Protein−DNA Interactions?
García-Nieto, R., Manzanares, I., Cuevas, C., & Gago, F. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000322d · Cited by 33
Sinhababu, A. K., Ghosh, A. K., & Borchardt, R. T. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00147a027 · Cited by 31
Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis
Lebedinsky, C. A., Gómez, J., Park, Y. C., Nieto, A., Soto-Matos, A., Parekh, T. V., Alfaro, V., Roy, E., Lardelli, P., & Kahatt, C. M. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1614-z · Cited by 27
Beumer, J. H., Buckle, T., Ouwehand, M., Franke, N. E. F., Lázaro, L. L., Schellens, J. H. M., Beijnen, J. H., & van Tellingen, O. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-7773-9 · Cited by 18
Clinical and pharmacokinetic evaluation of trabectedin for the treatment of soft-tissue sarcoma
Cioffi, A., & Italiano, A. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.636353 · Cited by 4
Rinehart (2000) · doi:10.1002/(sici)1098-1128(200001)20:1<1::aid-med1>3.0.co;2-a
Cited by
Biosynthetic Pathways to Nonproteinogenic α-Amino Acids
Hedges, J. B., & Ryan, K. S. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00408 · Cited by 183
Metadata
- Authors
- Le, V. H., Inai, M., Williams, R. M., & Kan, T.
- Venue
- Natural Product Reports
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2015
- Volume
- 32
- Issue
- 2
- Pages
- 328-347
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2068117029
- Cited by
- 167
- References
- 71
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.